Skin Disorders News

Children with eczema and sleep disturbances demonstrated an increased risk for headaches when compared with children who only had the skin disease, according to results from a population-based study.

Inhaled epinephrine appeared to have no effect on reducing hospital stay in children with acute bronchiolitis who developed recurrent bronchial obstruction episodes, atopic eczema or allergic sensitization by 2 years of follow-up, according to study results.

C1-inhibitor replacement through subcutaneous dosing of CSL830 appeared to create a predictable dose-dependent increase in functional c1-inhibitor levels in patients with mild to moderate hereditary angioedema, according to results of a phase 2 trial.

Nickel in a patient’s diet, in a medical implant or as an ingredient in topical medication could cause allergic contact dermatitis, according to a presentation at the American Academy of Dermatology’s 2015 Summer Academy Meeting in New York.

Chronic hives greatly affected the quality of life of patients with the skin disease compared with healthy controls, according to study results.

Atopic dermatitis increased the likelihood of patients developing certain immune-mediated inflammatory diseases, according to study results.

Provectus Biopharmaceuticals announced financial results of its second quarter of 2015 and provided updates on the development of new therapies for dermatology and oncology.

Patients with moderate-to-severe atopic dermatitis treated with Xeljanz showed reductions in signs and symptoms of the disease, according to recently published study results.

Maternal atopic history and high fat mass in newborns increase the risk for atopic dermatitis in infants, according to study results.

Desensitization may be successful in limiting the severity of adverse reactions people with inflammatory bowel disease experience when using infliximab, according to study results.